graphic of neurons graphic of a white gradient Where executive search unites the best people in innovation and life science. graphic of a white gradient RETAINED SEARCH BOARD SERVICES EXECUTIVE INTERIMS graphic of a white gradient Retained Search play_circle_outline Executive Interims play_circle_outline Board Services play_circle_outline

graphic of coding in the shape of data strands Nick Stephens, Executive Chairman, The RSA Group MEET THE TEAM NICK'S BIO image of Nick Stephens We are all part of a scientific revolution, a special moment in health care where the discovery of innovative therapies, diagnostics and treatments is accelerating exponentially, and the landscape is evolving at pace. “We may only be one small ingredient in this cauldron of brilliance but being an impactful part of it is what drives us every single day! It’s what makes our team dig deeper into the industry to ensure we have the best insights and networks, enabling us to be one step ahead of the game. We take the time to find the best talent, then we nurture and build personal relationships, so much so that often we know what our clients need before they do!”

News and Views

LATEST NEWS

28 Apr 2021
Inside the Minds of People at the Cutting Edge of Life Science: How Great Leaders Think
Read more
16 Apr 2021
Patrick Hoyle joins The RSA Group as Infrastructure Manager
30 Mar 2021
The RSA Group completes search for Clinigen Group – Sharon Curran appointed as Non-Executive Director
29 Mar 2021
Placement | The RSA Group completes successful search for Fusion Antibodies – Dr Richard Jones appointed as Chief Executive Officer

RSA Viewpoints All RSA Viewpoints | Podcasts

06 Jul 2021
Inspiring Leaders | Virginie Buggia-Prevot

Following a PhD in neurobiology and a post doc at the University of Chicago, Virginie Buggia-Prevot joined MD Anderson’s Neurodegeneration Consortium, managing strategic alliances and working on drug discovery. The… Read more »

Read more

Twitter

@theRSAgroup

Global appetite for UK #biotech #investment is showing no signs of slowing down! New analysis from the first half of 2021 has revealed that biotech shares continue to out-perform the wider market.

Read the full story 👉 https://bit.ly/3r9v0Qp

#innovation #science #investors

Reply on Twitter 1415607814815424515Retweet on Twitter 1415607814815424515Like on Twitter 14156078148154245152
Load More...
Follow us

RSA Consulting Ltd & RSA Interims Ltd
Registered office
85 Tottenham Court Road
London
W1T 4TQ

Registered in England as:
RSA Consulting Ltd. Company Number 01803896
and RSA Interims Ltd. Company Number 08433229

© 2021 The RSA Group.

Website designed and built by Happy Giraffe